LATEST WEBINARS
Webinar live date: Thursday 25 July 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Learn about the most advanced methods for quantitating and characterizing therapeutic oligonucleotides.
Live date Tuesday 23 July 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Register for our exclusive panel discussion focusing on the new ICH M10 guideline on bioanalytical method validation.
Webinar live date: Thursday 18 July 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Join us for a discussion on how bioanalytical data is used in early-phase clinical trials to advance drug development.
Webinar available to view on demand. Learn how using serial immunoaffinity (IA) enrichment and targeted MS offers the possibility to measure multiple protein targets with great sensitivity from a single sample.
Panel discussion available to view on demand. In this free panel discussion, our experts will provide insights into their own research using flow cytometry including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
Webinar available to view on demand. Register for our exclusive Coffee Chat focusing on patient-centric sampling. This informal discussion centers on this new type of workflow that benefits the patient, enabling the collection of previously difficult data.
Available to view on demand. Receptor occupancy measurement by flow cytometry is a rapid, quantifiable and an important addition to PK and PD data in the biopharmaceutical development process.
Webinar available to view on demand. Quantitative, sensitive and specific bioanalytical methods for the investigation of therapeutic oligonucleotides in biological matrices
Webinar available to view on demand. This webinar will detail strategies for improving recovery, sensitivity and repeatability in challenging peptide bioanalytical workflows, while maximizing the utilization of small sample size.
Webinar available to view on demand. Arno Kromminga and Lydia Michaut will discuss the strategies and challenges of immunogenicity assessment for gene therapy compounds.
In this free on demand panel discussion, our experts provide insights into their own research with cellular and gene therapies including the challenges they have had to overcome, key trends they have seen and their future outlook of the development of this field.
Latest News
Researchers have discovered unique populations of neurons in the spinal cords of patients who died of amyotrophic lateral sclerosis that could be utilized as potential drug targets.
A novel artificial intelligence and biosensor device has been developed to monitor if live caner cells remain after chemotherapy treatment.
Take a look at our overview of the top events in the world of bioanalysis for July, August and September 2019.
Latest Features
Complete our short survey on ligand binding assays and be the first to receive our informative infographic collated from the survey results.
As part of our Spotlight on flow cytometry, we carried out a survey to gain an insight into the trends, challenges and developments associated with this technique – find out the results in this informative infographic.
In this interview, Wenying Jian (Janssen Research & Development, Johnson & Johnson; NY, USA) describes the basic principles of hybrid LBA/LC–MS and how this technique can be used to quantify proteins.
Drug Discovery and Development
Drug detection in biological specimens: recent colorimetric methods
Signal amplification technology reveals previously undetectable proteins of disease
Bioanalytical laboratory considerations for immuno-oncology drug development
Ligand-binding
Biotherapeutic characterization and quantification: an interview with Pegah Jalili
Hybrid assays: the next big thing?
Evolution of fit-for-purpose biomarker validations: an LBA perspective
Mass Spectrometry
A multiplex HRMS assay for quantifying selected human plasma bile acids as candidate OATP biomarkers
Advancing mass spectrometry technologies: an interview with Neil Walsh
Signal amplification technology reveals previously undetectable proteins of disease
Sample preparation, extraction & collection
Identifying critical quality attributes using Agilent AdvanceBio Columns